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Iron is an essential micronutrient required by every human 
cell and has the capacity to accept and donate electrons 
readily by interconverting between ferrous, depicted as 
Fe(II), and ferric, depicted as Fe(III), forms. Hence, iron 
is important for oxygen transport, energy transfer, and 
nucleic acid biosynthesis. A normal adult man has 40–
50 mg iron/kg body weight (Andrews, 1999; Wessling-
Resnick, 2000). Although only about 0.1%–0.2% of iron 
(~7mg) is bound to transferrin (Tf) in extracellular fluids 
for transit, the turnover of this transported pool is highly 
dynamic, reaching 30–35 mg/day (Hirota, 2018; Sherwood 
et al., 2018; Wessling-Resnick, 2000).
The molecular basis of dietary iron absorption into 
the body is currently quite well understood. Dietary iron 
is absorbed mainly in the duodenum, either as ferrous 
iron transported across the apical membrane of the 
enterocyte via divalent metal transporter-1 (DMT1), or as 
heme iron transported possibly via the heme-responsive 
gene HRG (Knutson, 2017)  or HCP1 (Lawen and Lane, 
2013). Once inside the enterocyte, the iron can be stored 
or exported across the enterocyte basolateral membrane 
by the ferrous iron exporter ferroportin (FPN) (Knutson, 
2017). Hephaestin (Hp) increases the efficiency of this 
process by oxidising the transported iron to its ferric form 
and promoting its release from FPN (Crichton, 2009; Han, 
2011; Lawen and Lane, 2013; Deshpande et al., 2017), from 
which it is rapidly bound to apo-Tf for transport in the 
circulation to tissues (Lawen and Lane, 2103; Knutson, 
2017). In short, Hp plays a role in the uptake of iron from 
the diet, whereas Cp helps with the redistribution of iron 
to the cells and tissues; however, how Hp interacts with Tf, 
Cp, and FPN is still unclear.
To understand this mechanism, iron metabolism-
disordered animals, e.g., knockout (KO) mice and sla mice, 
have been studied as useful models of iron homeostasis. By 
studying sla mice, Hp was identified as a key component 
of intestinal iron transport. Sla mice develop moderate to 
Abstract: Hephaestin (Hp) is a trans-membrane protein, which plays a critical role in intestinal iron absorption. Hp was originally 
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cumulation of dietary iron in duodenal cells, causing severe microcytic hypochromic anaemia. Although mucosal uptake of dietary iron 
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roxidases (MCFs) and possesses ferroxidase activity that facilitates iron release from the duodenum and load onto the serum iron trans-
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secretory form tagged with green fluorescent protein (GFP), Hpsec-GFP. Plasmid expressing Hpsec-GFP was constructed and transfected 
into COS and CHO cells. The GFP aided the monitoring expression in real time to select the best conditions to maximise expression and 
provided a tag for purifying and analysing Hpsec-GFP. The protein had detectable oxidase activity as shown by in-gel and solution-based 
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severe microcytic hypochromic anaemia due to a block in 
intestinal iron transport—dietary iron is absorbed into the 
enterocyte, but export into the circulation is compromised. 
Hp has 50% sequence similarity with Cp, including the 
conservation of multiple copper binding sites (Vulpe et 
al., 1999; Griffiths et al., 2005) and is highly expressed in 
sla mouse intestine. Interestingly, in sla mice, this gene 
shows an in-frame deletion of 194 amino acids, probably 
resulting in a non-functional product (Ranganathan et al., 
2012a; Deshpande et al., 2017). The researchers conclude 
that this protein is a transmembrane-bound ferroxidase 
that plays an important role in the iron export mechanism 
involving FPN and Tf (Hudson et al., 2008; Vashchenko 
and Macgillivray, 2012; Lee et al., 2012; Chen, 2018; Zheng 
et al., 2018). The identification of mutant hephaestin as 
the gene responsible for the sex-linked anaemia in sla 
mice provides an important link between iron and copper 
metabolism in mammals (Lieu et al., 2001).
However,  recent investigations performed using 
intestinal Hp knockout indicate that the link between Hp 
activity and iron absorption is not simple (Doguer et al., 
2017).
In the current study, we have investigated the 
recombinant Hpsec-GFP plasmid prior to transfection in 
the COS cell system to study the expression of bioactive, 
recombinant soluble hephaestin in COS and CHO cells 
and then to assess its ferroxidase activity and iron efflux 
ability.
In the current study, the main aim was to understand 
and investigate the role of Hp systemic iron homeostasis 
by studying the activity assays and expression studies.
Therefore, microscopy was used to study the 
intracellular distribution of Hp and ascertain whether the 
correct protein is expressed. The data for the recombinant 
GFP-tagged Hp plasmids showed different patterns of 
expression. Full-length Hp-GFP was also constructed to 
confirm the localisation of Hp for further analysis, but the 
data are not shown here.
2. Materials and methods
2.1. Construction of soluble hephaestin protein
The Hp cDNA from mouse was subcloned from pcDNA3.1 
into pEGFP-N3 as an expression vector for the expression 
of GFP-tagged proteins in eukaryotic cells to create GFP-
tagged soluble and full-length forms of hephaestin (2 
separate subcloning works, full length and truncated). 
For the soluble/secretory form of Hp devoid of the 
transmembrane domain (TM), a C-terminus fragment 
upstream of the TM domain was amplified using the primers 
Heph5 (5’-TCTGCAGAAATGGTATCTTGGAACC-3’) and 
Heph3A(5’-CCGAATTCAAGCGCTATCCTTTATGGGAA
TGTTCATGCCC-3’), including a stop codon introduced 
just prior to the TM domain (Figure 1).
2.2. PCR amplification
A 50 µL reaction was prepared by mixing on ice 200 nM 
of each dNTP, 50 ng of template DNA, and 0.4 µM of each 
primer in 1xVentRbuffer [20 mM Tris-HCl (pH 8.8), 10 
mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton 
X-100]. Fifty µL of mineral oil were layered on top, and 
the reaction was subjected to a hot start treatment, i.e. the 
above reaction mix was incubated for 3–5 minutes at 94 
°C before the addition of 2 U of VentR polymerase (New 
England Biolabs, Ipswich, MA, USA). Thermal cycling 
parameters were as follows: DNA denaturation at 94 °C 
for 1 min; primer annealing for 1 min at a temperature 
range of 55–72 °C, which was determined empirically 
for each template/primer pair; and primer extension at 
72 °C, allowing 1 min per kilobase of expected extension 
product. A total of 30 cycles were carried out, followed by 
the incubation of the reaction at 72 °C for 10 min.
The PCR fragment was digested with HpaI and EcoRI 
restriction enzymes and gel purified prior to subcloning 
into the pcDNA3.1-Heph via HpaI and EcoRI sites (Figure 
1) to create a cDNA, encoding a soluble/secretoryform 
of Hp (Hpsec). The truncated Hp construct was then 
subcloned into the Eco47III site of the pEGFP-N3 vector 
via AflII (blunted) and Eco47III to generate a cDNA, which 
expresses the recombinant Hpsec-GFP. The recombinants 
with correct orientation were selected by digestion with 
XhoI and the mutations were verified by sequencing.
2.3. Cloning and expression of the Hp protein
The bacterial cells INVαF’, JM109, and MC1061/P3, 
and the cloning vectors pcDNAI and pcDNA3.1 were 
purchased from Invitrogen (Paisley, UK). The pEGFPN3 
was purchased from Clontech (Nottinghamshire, UK). 
The pcDNA3.1 is a high level constitutive mammalian 
expression vector. It has the hCMV promotor, which is 
able to drive high levels of transcription in a wide variety 
of mammalian cells (Foecking and Hofstetter, 1986). The 
NovaBlue E. coli K12 strain and the pSTBlue-1 vector 
were purchased from Novagen (Nottingham, UK). 
The pSTBlue-1 is also a multipurpose bacterial cloning 
and expression vector with versatile MCS, T7, and SP6 
promoters and ampicillin and kanamycin resistance genes.
2.4. The COS cell system and passaging of cells
The COS-7 cells were obtained from the European 
Collection of Animal Cell Cultures. The cells were 
cultured in 9 cm disposable culture dishes in a moist 
atmosphere of 95% air and 5% CO2 at 37 °C. The COS 
cells were subcultured before confluency in the log phase 
of growth. The spent medium was discarded, and the 
monolayer of the cells was dislodged from the plate with 
a solution of 1x trypsin at 37 °C for 10 min. The cells were 
collected, sedimented, and the cell pellet was resuspended 
in complete RPMI 1640. Fresh plates were seeded with 
1/10 volume of cell suspension and topped up with 9 mL of 
fresh medium.
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2.5. Transfection using DEAE-Dextran
A day before the transfection, 3–5 x 105 cells per 9-cm 
culture dish were seeded. For each 9-cm dish, a transfection 
solution was prepared comprising 4.0 mL serum-free 
RPMI 1640, containing 200 mg/mL DEAE-Dextran and 
10 mg of plasmid DNA, and the pH was adjusted to 7.4 
with 0.4 mL 0.5 M Tris-HCl. After 24 h, the cells were 
washed 3 times with warmed serum-free RPMI 1640, and 
4 mL of DEAE-Dextran-DNA mixture was added to each 
dish. The cells were incubated at 37 °C for 4 h. They were 
washed twice with serum-free RPMI 1640 and were then 
exposed to a RPMI 1640 7% FCS (v/v) solution containing 
100 mM chloroquine and incubated at 37 °C for 3 h. 
Finally, the cells were washed twice, and cultured in full 
RPMI 1640 for 48–72 h.
2.6. Transfection of mammalian cells by electroporation
The electroporation of the COS and CHO cells was carried 
out using the preset protocol (160 V, 500 mF, exponential 
decay) in the Gene Pulser Xcell electroporation system 
(BioRad Laboratories, Inc., Philadelphia, PA, USA) 
experimentally with the optimum results obtained. The 
cells were pulsed once, immediately transferred to a culture 
dish, and cultured. Transient gene expression was assessed 
24–48 h following electroporation with a fluorescent 
inverted microscope (Olympus 1X51, Olympus UK Ltd, 
Middlesex, UK). The transfected cells were usually fixed 
in 2% (w/v) paraformaldehyde in PBS for 1 h at room 
temperature prior to observing GFP fluorescence. One day 
after plating on coverslips, the GFP-tagged Hp constructs 
were transfected into COS-7 and CHO. Then, the cells 
were fixed in 2% (v/v) formaldehyde in PBS for 10 min. 
The images were then collected using confocal microscopy 
(Carl Zeiss Microscopy GmbH, Oberkochen, Germany).
2.7. Measurement of the hephaestin and Cp protein 
oxidase activity assay
A) 0.1% o-dianisidine oxidase assay
The samples obtained from the cell culture were 
subjected to PAGE (10% gel) under native conditions 
(nondenaturing). After electrophoresis, the gel was briefly 
rinsed in 0.1 M sodium phosphate buffer with ph 5.7. The 
oxidase activity was assayed qualitatively by incubating 
with the same buffer containing 0.1% o-dianisidine (3, 
3´-Dimethoxybenzidine) and 30% ethanol at 37 °C for 
60 min. The gel was left at room temperature until the 
staining for oxidase activity was clearly visible.
B) p-phenylenediamine oxidase activity measurement
Serum ceruloplasmin p-phenylenediamine (PPD) oxidase 
activity was measured. At ph 5.6, ceruloplasmin catalysed 
the oxidation of ppd to yield a coloured product. The 
0.45 M acetate buffer solution with ph 5.8 was prepared 
as follows: 36.91 g of CH3COONa was dissolved in 1000 
mL of deionized water. Reagent grade glacial acetic acid 
(25.87 mL) was diluted to 1000 mL with deionized water 
(final concentration, 0.45 M). The sodium acetate solution 
(940 mL) was mixed with 60 mL of acetic acid solution 
under a ph meter; the ph of the acetic acid-sodium acetate 
buffer was 5.8. Then, 0.1 g p-phenylenediamine substrate 
was dissolved in sodium acetate buffer, treated with 
Chelex-100 by mixing by a rotator for 15–20 min, and 
centrifuged for 3–5 min at 700 rpm to collect the Chelex 
pellets to avoid interference in the assay. The buffer and 
sample mixtures were warmed at 37 ° C before the substrate 
was added at 1 min intervals. After this step, 10 μL (or 100 
μL) aliquots of the sample in lysis buffer were assayed in a 
total volume of 1.0 mL (or 10 mL). The absorbance of each 
sample at 530 nm was measured using the CECIL 1021 
Spectrophotometer at certain time intervals.
2.8. Western blotting
The proteins from SDS-PAGE were transferred to 
HybondTM-C extra membrane and optimised for protein 
transfer from Biosciences UK Ltd. (Amersham, UK) using 
a wet Western blot system (Hoeffer) run at 100 ma for 1.5 
h or 15 ma overnight. Following blocking with 1% (w/v) 
skimmed milk powder (Marvel) in 0.05% (v/v) Tween-20, 
TBS, the nitrocellulose was then incubated for 2 h with 
either rabbit antimouse hephaestin (Alpha Diagnostic 
International, Inc., San Antonio, TX, USA) or anti-GFP 
antibody (Abcam Ltd., Cambridge, UK). All antisera were 
diluted to 1:500 in TBS prior to use. The sheet was washed 
3 × 5min with TBS [0.05% (v/v) Tween-20]. Following 
the secondary antibody incubation, the membrane was 
incubated with 4 μL of streptavidin-alkaline phosphatase 
in 3 mL of 1% blocking buffer for 1 h in constant shaking 
at room temperature. The membrane was then incubated 
with freshly prepared substrate solution [60 μL of nitro-
blue tetrazolium (NBT) (Sigma-Aldrich Corp., St. 
Louis, MO, USA), 60 μL of 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP), and 5 mL of alkaline phosphatase 
buffer]. After the overnight incubation in darkness for 
band development, the membrane was washed with 
distilled water to quench the developing reaction.
2.9. Immunoprecipitation of recombinant hephaestin
Rabbit polyclonal anti-GFP antibody with a volume of 
0.5 µL was added to 10 mL of cell medium (or lysate) 
containing recombinant Hp and was incubated on ice for 1 
h. Then, 50 µL washed Pansorbin (10% (v/v) in lysis buffer: 
0.5% TX-100 in PBS) was added to the mixture and further 
incubated for 1 h at 4 °C on a rocking platform. The beads 
were pelleted by centrifugation at 10,000 g for 15 s at 4 °C, 
the supernatant was removed by gentle aspiration, and the 
immune complex was washed on the beads 3 times with 
lysis buffer. Each time, 1 ml of lysis buffer was added and 
the beads were resuspended by pipetting. Following this, 50 
µL of 1 × SDS gel-loading buffer was added to the washed 
pellet and the proteins were denatured by putting the tube 
in boiling water for 5 min. The sample was centrifuged for 
15 s at 10,000 g and the supernatant was loaded on the gel.
ASLAN et al. / Turk J Biol
396
3. Results
3.1. Expression of the recombinant Hpsec-GFP in the COS 
cells
GFP-tagged soluble Hp was prepared for expression 
studies (Figures 1 and 2). The Hpsec-GFP construct was 
initially tested in a COS cell system. The COS cells were 
chosen for transfection because of their convenience to 
generate stable cell lines. Moreover, they provide a high 
level of expression and are adherent cells and therefore 
quite appropriate for microscopy studies. The intracellular 
Figure 1. Plasmid construction for GFP-tagged secretory hephaestin. (A) The secretory form of 
hephaestin (Hpsec-GFP) was constructed for expression studies. (i) The full-length hephaestin 
cDNA was used as a template to amplify the 622 nt C-terminus fragment immediately upstream 
of the transmembrane I domain. (ii) The PCR product was religated into the pcDNA3.1 vector 
containing the N-terminal portion of hephaestin. Selected recombinants were sequenced 
through the full-length of the PCR amplicon. (iii) The recombinant hephaestin was fused to 
the N terminus of EGFP coding sequence. (B) The 3´ PCR primer was designed to include the 
Eco47III, EcoRI sites for the ease of subcloning and a stop codon. The single letter amino acid 
code is shown above the codons. The boxed region corresponds to the hephaestin sequence.
Figure 2. PCR products for generation of recombinant Hp constructs. 10 µL samples of PCR products were electrophoresed on a 1% 
agarose gel for 1 h at 100 mA. Lanes 1 and 2 contain the amplicons of the C-terminus of the secretory hephaestin construct produced 
using primers Heph5 and Heph3A described in Methods 2.1. Lane (M) is the 100 bp ladder (New England Biolabs). Lanes 3 and 4 
contain amplicons of the C-terminus of the full-length (wild type) Hp with stop codon ablated. 
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distribution of Hp was checked by fluorescence microscopy 
and the expression profile of Hp was compared with 
the control GFP expression system, which has a distinct 
expression pattern (Figures 3 and 4). 
Hpsec-GFP was transfected into the COS-7 cells using 
DEAE-Dextran or lipofectamine TM reagents. Figure 3 
shows the expression of these recombinant Hp molecules, 
which is the expected expression pattern for the soluble 
Hpsec-GFP construct. The pattern correlates well for a 
secretory protein localisation with a strong perinuclear 
expression, and a vesicular pattern of localisation 
throughout the cytoplasm, suggesting that the protein 
is likely to be secreted. Moreover, the expression profile 
was distinct from GFP control construct (Figure 4), in 
which staining was uniform throughout the cell, including 
the nucleus. Taken together, the patterns of localisation 
suggest that the construct is expressing chimeric Hpsec-
GFP with the patterns of localisation broadly expected 
for soluble protein. However, further experiments were 
needed to confirm that the correct protein was being 
expressed. Thus, the expression was further confirmed by 
Western blotting and biological activity was assessed by 
monitoring the oxidase activity.
3.2. Immunoprecipitation (IP) method for the 
preparation of GFP-tagged soluble hephaestin and the 
requirement of heating for elution
In this study, the recombinant soluble Hp protein was 
analysed from the cell culture medium from transfected 
CHO cells by using an anti-GFP antibody. The 
immunoprecipitation technique was used to increase the 
yield of proteins for the analysis. The expected size of the 
protein was 150 kDa for Hpsec-GFP, based on the size of the 
Hpsec and GFP polypeptides (Syed et al.,2002). Specific bands 
were successfully detected from the immunoprecipitated 
sample heated at the elution step, with molecular weight 
Figure 3. Expression of Hpsec-GFP in COS cells. (i) A strong green fluorescent signal was detected in the perinuclear region as indicated 
by the arrow in (B) with punctate signals throughout the cytoplasm, gradually decreasing in intensity, moving from the nucleus to the 
plasma membrane in the A, B, C, and D. (ii) Fluorescent signals (A and D) were checked by phase contrast shown in the middle panels 
(B and E); partial signal in C and F. Cells were transiently transfected using the DEAE-dextran method.
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of 175 kDa (Hpsec-GFP) (Figure 5, lane 5) on Western 
blot analysis. Hpsec-GFP was expressed in the CHO cells, 
which were cultured in the selection medium containing 
G418. The CHO cells expressing Hpsec-GFP took around 
14–16 days to reach t=70%–80%  confluency. During the 
culturing, the Hpsec-GFP expression was closely observed 
by fluorescent microscope because the collection time of 
the cell culture media was critical for the preparation of 
Figure 4. Expression pattern of GFP protein. GFP shows a distinct pattern in which staining is 
evident throughout the cell, inducing the nucleus and therefore are easy to compare with Hp-
GFP constructs showing in A and B. Cells were transiently transfected with pEGFP-N3 using the 
DEAE-dextran method.
Figure 5. Identification of the recombinant Hpsec-GFP protein from CHO cells by Western blot. The cell culture medium or extracts 
were immunoprecipitated with rabbit anti-GFP antibody, incubated with Pansorbin and detected with the same antibody. The protein 
samples were electrophoresed on a 10% gel blotted and analysed with anti-GFP antibody and the figure shows immunoprecipitated 
samples prepared with heating at 90 °C for 5 min vs. those prepared without heating. Lane 1 contains broad range protein standard 
(New England Biolabs); lane 2 represents a negative control, immunoprecipitation of medium; lanes 3 shows a negative control, 
immunoprecipitated medium from untransfected CHO cells; lanes 4 and 5 are Hpsec-GFP prepared from transfected medium which 
gave a correct band for the sample eluted by heating (lane 5) at the end of precipitation, around 175 kDa indicated by arrow, but only 
a faint band for the sample prepared from the same medium but without heating (lane 4). Lanes 6 and 7 show immunoprecipitates 
prepared Hpsec-GFP cell extract, no band for the unheated samples of soluble hephaestin; lane 8 represents positive control, transfected 
IRP1-GFP which is around 125 kDa. The figure shows that the heating was necessary to elute the protein.
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the sample. Therefore, cell culture studies were strictly and 
carefully followed. The cell culture media were collected 
from 3 plates, making the total volume between 30–50 mL 
(9-cm dish), and then the immunoprecipitation technique 
was carried out. An important part of the technique was 
the elution step, which was performed by heating the 
Pansorbin carrying the immunoprecipitates at 90 °C for 
4–5 min. Although heating elution was potentially very 
risky for the protein, the Hpsec-GFP prepared by heating 
yielded effective results.
Specific bands were also successfully detected from 
immunoprecipitates prepared from the transfected COS 
cells, also with a molecular weight of 175 kDa (Hpsec-
GFP) (Figure 6). The expected size of the recombinant 
polypeptide for the Hpsec-GFP polypeptide was 150 kDa 
(Syed et al., 2002). The difference between the predicted 
polypeptide size and the actual size of the recombinant 
product could be due to glycosylation, which will be 
further confirmed. Once again, the bands were observed 
when immunoprecipitates were eluted with heating 
(Figure 6, lanes 2 and 3). One set of COS cells were treated 
with 20 µM CuSO4 to see whether the yield of Hpsec-GFP 
would be increased (Figure 6, lane 3). However, there 
was no observable difference compared with Hpsec-GFP 
prepared from untreated cells (Figure 6, lane 2).
3.3. Oxidase activity of the recombinant hephaestin
Having established that Hpsec-GFP can be successfully 
expressed, oxidase activity was assessed by the method 
of Johnson et al. (1967). Hpsec-GFP was purified from 
the medium using immunoprecipitation with a rabbit 
polyclonal antibody directed against GFP. The extracted 
protein was run on a native gel and oxidase activity 
was assayed using α-phenylenediamine/o- dianisidine 
substrate. Purified human Cp was used as a positive 
control. In the first experiments, the immunoprecipitates 
were compared for oxidase activity and protein content 
following electrophoresis of duplicate samples on the 
same gel (Figure 7). A single band of oxidase activity is 
evident (Figure 7A), which has the same mobility as a 
single band of protein identified by Coomassie staining 
(Figure 7B). The same preparations were analysed for 
oxidase activity (Figure 8A) and for Hpsec-GFP expression 
by Western blotting (Figure 8B). Cp was used to compare 
oxidase activity (Figure 8A, lane 1) in the nondenaturing 
gel and had a faster mobility than Hpsec-GFP (Figure 8A, 
lane 2). The Hpsec-GFP prep gave a single band of 175 
kDa on Western blotting (Figure 8B). Similarly, the Hpsec-
GFP expressed from the COS cells also had a measurable 
oxidase activity (Figure 9). Taken together, these data 
demonstrate that Hpsec-GFP has oxidase activity and that 
Figure 6. Western blot analysis of the hephaestin-GFPs expressed from COS cells. The cell culture medium or cell extracts were 
immunoprecipitated with rabbit anti-GFP antibody, incubated with Pansorbin and detected with the same antibody. The protein 
samples were electophoresed on a 10% SDS gel. Lane M contains broad range protein standards (New England Biolabs); lanes 2 and 3 are 
immunoprecipitates of medium from cells, transfected with pHpsec-GFP treated without and with Cu
2+ respectively, eluted with heating; 
lane 4 represents a negative control, the immunoprecipitate of untransfected COS cell medium; lane 5 represents cellular extracts of 
untransfected COS cells (negative control); lanes 6 and 7 are extracts of Hpsec-GFP transfected cells treated without and with Cu
2+ 
respectively. Recombinant soluble hephaestin could be detected in immunoprecipitates of cell culture medium, but not of cell lysates.
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Figure 7. Coomassie staining and Oxidase activity of hephaestin expressed from CHO cells. 
10% PAGE under nondenaturing conditions was used to separate the Hpsec-GFP expressed 
from CHO cells in the medium. Duplicates of Hpsec-GFP samples were loaded. After 
electrophoresis, the gel was cut in half and treated differently according to the protocols. 
Bands were identified with coomassie staining and oxidase assay on nondenaturing gel. (A) 
Oxidase staining was performed with o-dionisidine for the oxidase activity. Lane 1 contains an 
immunoprecipitated of Hpsec-GFP. (B) Coomassie staining was performed for 1 h in staining 
solution prior to overnight incubation in destaining solution; lanes 2 and 3 contain the 
secretory hephaestin purified by immunoprecipitation from transfected medium expressed 
in CHO cells; lanes 4 contain extract of CHO cells expressing full-length hephaestin and lanes 
5 contains dialysed histidine tagged hephaestin. Western blot analysis confirms presence of 
single band of 175 kDa and oxidase activity was detected for the Hpsec-GFP sample from the 
same preparation (Figure 8).
Figure 8. Gel oxidase assay and western blotting of hephaestin expressed from CHO cells. 10% PAGE under nondenaturing conditions 
was used to separate the Hpsec-GFP expressed from CHO cells in the medium. After electrophoresis, the gel was cut in half and treated 
differently for oxidase assay and Western blotting analysis for the same set of samples. Bands were confirmed to be hephaestin both 
with oxidase staining and by western blotting on native on nondenaturing gel. (A) Oxidase staining was performed with o-dionisidine 
for the oxidase activity. Lane 1 contains 5 µg of ceruloplasmin (Cp) as positive control; lane 2 represents the secretory hephaestin 
purified by immunoprecipitation from transfected medium expressed in CHO cells. (B) Western blot analysis of immunoprecipitated 
Hpsec-GFP expressed from CHO cells. Lane M contains broad range protein standards (New England Biolabs); lane 2 represents an 
immunoprecipitated pHpsec-GFP from CHO cells and lane 3 shows the immunoprecipitate of untransfected CHO cell medium. The 
arrows indicate the bands of Hpsec-GFP from either gel, which had the same mobility.
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the recombinant protein has folded successfully even 
though it is a secretory form.
3.4. The measurement of solution-based oxidase 
activityor p-phenylenediamine oxidase activity 
Having established that the recombinant Hpsec-GFP 
had oxidase activity, it was of interest to use a solution-
based oxidase assay to obtain quantitative data. Stably 
transfected CHO cells were used to express Hpsec-GFP. 
The expressed Hpsec-GFP was obtained 14–16 days after 
the transfection and the expression level was checked by 
fluorescence microscopy 3 times a week. Each time, fresh 
medium containing G418 was added. When the Hpsec-
GFP cells reached an expression level of 70%–80%,the cell 
medium was collected from 3 or more plates. The samples 
were prepared by immunoprecipitation from a total of 50 
mL cell medium and the samples were eluted by heating at 
90 °C for 4–5 min.
Oxidase activity was assayed by the method of Sato and 
Gitlin (1991). The Hpsec-GFP oxidase activity was assayed 
using α-phenylenediamine substrate. Protein was assayed 
by the Bradford method and the equivalent amounts were 
assayed per experiment, typically about 5 µg protein. 
Oxidase activity could be detected in immunoprecipitates 
from the medium of cells expressing Hpsec-GFP. Figure 10 
shows data from one set of assays. 
In this experiment, the effect of elution by heating 
was analysed by preparing the immunoprecipitates with 
and without heating on the final stage of protein elution. 
As seen on the graph (Figure 10A), heating is necessary 
to elute activity after immunoprecipitation. The samples 
were stored at 4 ºC for 10 days and reassayed. Figure 10B 
shows that oxidase activity was lost over this period, and 
that freshly prepared samples had to be used shortly after 
preparation for oxidase studies.
3.5. The effect of copper on the expression and activity of 
the hephaestin protein
The availability of copper in the system may also 
contribute to the levels of expressed hephaestin. In order 
to address this concern, 20 µM Cu2+was supplemented to 
the medium to try to increase the yield of proteins. Further 
addition of copper did not seem to increase the levels of 
expression. The possible reason could be the toxic effect of 
copper on cells because the survival times of cells treated 
with Cu2+were shorter than cells without extra Cu2+.
In this experiment, the cells were treated with/out 
copper to investigate the requirement of copper for 
oxidase activity. Stably transfected CHO cells expressing 
Hpsec-GFP had a slight increase in oxidase activity when 
treated with copper, compared with untreated samples, 
but on Western blots, no band was detected from either 
treated or untreated samples. Even though a slightly 
increased oxidase activity was found, the cells treated 
with copper were less viable and protein yields were low. 
Future work is needed to investigate the effect of copper 
Figure 9. Oxidase activity of hephaestin expressed from COS cells. 10% PAGE under non-
denaturing conditions was used to separate the Hpsec-GFP expressed from COS-7 cells in the 
medium. Lanes 1 and 2 contain 5 µg of ceruloplasmin (Cp) as positive control, and lanes 3 and 
4 contain the secretory hephaestin purified by immunoprecipitation from transfected medium 
expressed in COS-7 cells. Staining was performed with o-dionisidine for the oxidase activity. 
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of lower concentrations to find the optimal concentration 
to increase yield without affecting cell growth (Figure 11).
4. Discussion
In recent years, a number of key proteins involved in 
iron metabolism have been identified, although this 
information has not necessarily clarified certain aspects 
of cellular iron metabolism. Hp was identified as a key 
component of intestinal iron transport through the study 
of sla mice (Vulpe et al., 1999; Ranganathan et al., 2012a).
The expression construct for Hpsec-GFP (Figures 1 and 
2) produces a protein which is analogous to Cp, a soluble 
serum protein produced in the liver. On microscopy, 
the secretory form of Hp gave a strong green fluorescent 
signal in the perinuclear region with punctuate signals in 
the cytoplasm, gradually decreasing in intensity, moving 
from the nucleus to the plasma membrane (Figures 3 
and 4). The expression profile of Hp is distinct among 
the molecules involved the iron metabolism pathway. In 
our results, this profile is consistent with the expression 
expected for soluble proteins (Shen et al., 2005).
The COS cell and CHO expression systems used in 
this study produced usefully measurable amounts of 
the recombinant Hpsec-GFP protein, as was confirmed 
by Western blotting of immunoprecipitates from the 
transfected COS and CHO cell media (Figures 5 and 6). The 
expected size of protein was 150 kDa for Hpsec-GFP (Syed 
et al., 2002) and specific bands were successfully detected 
from immunoprecipitates with a molecular weight of 175 
kDa according to Western blot analysis. Glycosylation 
was expected to account for the difference between the 
recombinant products with a predicted polypeptide size of 
150 kDa and the actual size of 175 kDa.
In an attempt to confirm this expectation, the set of 
samples was treated with Endo H enzyme to remove the 
carbohydrate chains. However, this treatment did not 
result in a change in the product size, possibly indicating 
that sugar moiety was resistant to this enzyme.
Through the use of in-gel assays with an o-oxylamine 
or phenylenediamine substrate, the Hpsec-GFP protein was 
shown to possess oxidase activity (Figures 7–9). During the 
current study, several experiments showed that heating was 
Figure 10. Oxidase assay of recombinant Hpsec-GFP for heated and unheated samples. (A) Oxidase activity of heated soluble hephaestin 
expressed in CHO cells. The active samples have about 30% activity above the negative controls. Immunoprecipitated protein eluted 
with heating on the final stage of preparation has more activity than unheated precipitates. As seen on the graph Hpsec-GFP (unheated), 
so heating is necessary to elute activity after immunoprecipitation. (B) Oxidase assay of recombinant Hpsec-GFP for heated and unheated 
samples after 10 days storage at 4 °C: Immunoprecipitated medium of Hpsec-GFP sample with heating on the final stage of protein elution 
are orange and Hpsec-GFP without heating are green which were assayed after 10 days; blues represent CHO and control; pink are the 
medium as negative control. Oxidase activity of the soluble hephaestin samples were assayed after 10 days showed less activity than 
freshly assayed ones (see Figures 10A and 10B). Data are the means of duplicates and are single experiments representative of three 
batches. Error bars are omitted for clarity and standard deviations were less than 15% of the mean.
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necessary for the elution step of the immunoprecipitation; 
the samples without heating did not yield any protein 
and activity (Figures 5 and 10). Although the elution of 
a protein by heating is risky, the Hp samples prepared by 
heating did not denature. Attempts were made to assay the 
oxidase activity of the immunoprecipitates still bound to 
Pansorbin cells, but they were not accurate. As such, it was 
not possible to measure how much oxidase activity may 
have been lost by the heat treatment (Figure 10). Its ability 
to withstand heat treatment shows that Hp has a stable 
structure, but this may be because GFP helps stabilise the 
protein. These results indicate that the recombinant protein 
folds properly and has copper correctly incorporated into 
it in order for it to have biological activity. 
Interestingly, Kuo et al. (2004) demonstrated the 
presence of detectable oxidase activity for the truncated 
protein in sla mice, suggesting the possibility that other 
factors may also contribute to the decreased iron exit in 
sla mice. Indeed, it was also reported that the Hp protein 
is mislocalised in sla enterocytes. It has been suggested 
that the Hp ferroxidase activity may be necessary for the 
effective release of iron from enterocytes, with or without 
FPN interaction, in order to transport iron across the 
basolateral membrane (Vulpe et al., 1999). The exact 
role of Hp in the efflux process therefore still remains 
unknown, but it is important to note that the possible sites 
for Hp action might be on the basolateral surface with the 
C-terminus in the cytoplasm, or in a vesicle (Syed et al., 
2002; Ranganathan et al., 2012b).
 As noted above, Hp is a copper-containing protein 
homologous to Cp, and its ferroxidase activity may aid the 
binding of iron to apotransferrin since only Fe(III) binds 
(Linder et al., 2003). Interestingly, according to Chen et 
al. (2006), copper is likely not necessary for the proper 
folding or assembly of most copper proteins, including 
the multicopper oxidases. Furthermore, it does not 
dramatically alter their subsequent stability (Chen et al., 
2006). Genetic or nutritional copper deficiency does not 
change the levels of inactive apo-Cp, although the protein 
has a decreased plasma half-life. In contrast, the finding 
that copper deficiency decreased the Hp protein levels 
suggests an unexpected and unusual link between copper 
availability and protein stability (Figure 11).
The availability of copper in the system may contribute 
to the levels of expressed Hp. Further studies are needed to 
determine whether copper has a role in Hp expression and 
whether the protein level and oxidase activity are reflective 
of a copper-related process. To address this concern, an 
additional 20 µM Cu2+ was added to the medium to try to 
increase the yield of proteins in the system. This addition 
of copper did not increase the levels of expression. The 
possible reason is that the addition of a higher concentration 
of copper or a nonoptimal concentration of copper to 
the cells could exert toxic effects on cells. Although the 
copper-treated cells had some oxidase activity, no band 
was detected on Western blotting analysis; therefore, only 
this single dose was applied during this analysis (Figure 
11).
Figure 11. Oxidase assay showing activity of soluble hephaestin expressed from cells with 
and without copper treatment. Oxidase activity of soluble hephaestin expressed in CHO cells 
treated with/out Cu+. Cells treated with 20 µM copper are in dark red; cells without copper 
treatment are orange. Cu+ treated cells showed more activity than cells without Cu+ treatment, 
but there were no significant differences on repeated assays (data not shown here). Data are 
the means of duplicates and are single experiments representative of three batches. Error bars 
are omitted for clarity and standard deviations were less than 15% of the mean.
ASLAN et al. / Turk J Biol
404
According to the literature, intestinal iron transport 
pathways are also Cu sensitive. It has been suggested that 
copper deficiency chronically impairs Hp activity, which 
leads to inefficient basolateral intestinal iron export, as 
evidenced by increased enterocyte ferritin levels and 
systemic iron deficiency and anaemia. It was found that 
copper deficiency does not affect Hp transcript levels in 
HT29 cells but results in dramatic decreases in Hp protein 
and PPD oxidase activity. Together, these studies provide 
evidence that copper deficiency does not change mRNA 
levels but decreases Hp protein levels and subsequently 
oxidase activity. The mechanisms of copper loading into 
copper proteins in the secretory pathway are not known 
and need to be clarified (Chen et al., 2006).
5. Conclusion
In summary, we were able to produce a recombinant 
secretory form of Hp tagged with GFP. The GFP tag was 
helpful for monitoring the expression levels in real time, 
helping to optimize conditions for the maximal expression 
and also providing a tag for purifying and analysing 
the protein. We were able to demonstrate a measurable 
oxidase activity of the recombinant protein. We also 
demonstrated that heating the immunoprecipitates 
prepared using Pansorbin to 90 °C was necessary to free 
Hp for analysis. Despite the high temperature used, Hp 
had a demonstrable oxidase activity, suggesting that 
the recombinant protein was very stable. The methods 
described here provide a versatile means of producing 
recombinant Hp under conditions that can be easily 
achieved. In particular, the preparation of a secretory form 
of tagged fluorescent hephaestin may allow further studies 
to probe its interaction with transferrin, for example by 
fluorescence resonance energy transfer.
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